[1]
Rico-Fontalvo, J., Daza-Arnedo, R. , Cabrales , J. and Montejo-Hernández, J.D. 2022. Semaglutide in Overweight and Obese patients: Cardiovascular and/or Renal Metabolic Benefits . Revista Colombiana de Nefrología. 9, 3 (Oct. 2022). DOI:https://doi.org/10.22265/acnef.9.3.614.